Clinical Trial: Study Comparing the Efficacy and Tolerance of Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy of Brain Metastases.

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07437820) titled 'Study Comparing the Efficacy and Tolerance of Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy of Brain Metastases.' on Feb. 23.

Brief Summary: The purpose of this study is to evaluate the local control rate on the target lesion at 6, 12, and 24 months after treatment with neoadjuvant stereotactic radiotherapy (SRS NEO group) compared to standard care, adjuvant stereotactic radiotherapy (POST OP SRS group).

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Brain Metastases, Adult

Intervention: RADIATION: stereotactic radiotherapy

Stereotactic radiotherapy is part of the standard treatment for brain meta...